Eczema probiotic trial for kids ends early – too few participants

NCT ID NCT05443490

Terminated Disease control Sponsor: Bionou Research, S.L. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a probiotic supplement for children aged 6 months to 3 years with mild-to-moderate eczema. The goal was to see if the probiotic could reduce eczema severity and the need for steroid creams. However, the trial was terminated early and only enrolled 4 children, so no meaningful conclusions can be drawn.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: probiotic mixture (three bacterial strains)
What this could lead to: If it worked, this could point toward a probiotic supplement to help manage eczema in young children.
What could go wrong: The trial was terminated early with only 4 participants, so we cannot draw any reliable conclusions. Probiotics may not affect eczema severity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS

Contacts and locations

Locations

Centro de Especialidades Dermatológicas Ac S.A (Dermaláser)

San José, Provincia de San José, Sabana Oeste, T. Médica 20/20, Costa Rica
Hospital Universitario del Vinalopó

Elche, Alicante, 03293, Spain
Hospital del niño Dr. Ovidio Aliaga Uria y Hospital Arco Iris

La Paz, La Paz Department, 10097, Bolivia

More trials for these conditions

Other studies related to the condition(s) this trial covers.